Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway

Journal of Infectious Diseases

Volumn 186, Issue 2, 2002, Pages 155-163

  Kato, Jun ^a   Kato, Naoya ^a   Moriyama, Masaru ^a   Goto, Tadashi ^a   Taniguchi, Hiroyoshi ^a   Shiratori, Yasushi ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CAPPED RNA; DOUBLE STRANDED RNA; GLYCYRRHIZIC ACID; INTERFERON; METHYLPREDNISOLONE; PROTEIN KINASE; RIBAVIRIN; URSODEOXYCHOLIC ACID;

ANTIVIRAL ACTIVITY; ARTICLE; DOSE RESPONSE; DRUG EFFECT; ENCEPHALOMYOCARDITIS VIRUS; ENZYME ACTIVATION; FOOT AND MOUTH DISEASE VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INTERNAL RIBOSOME ENTRY SITE; PRIORITY JOURNAL; REPORTER GENE; RNA TRANSLATION;

ANTI-INFECTIVE AGENTS; ANTIVIRAL AGENTS; AUTOANTIGENS; BLOTTING, WESTERN; CHOLAGOGUES AND CHOLERETICS; ENCEPHALOMYOCARDITIS VIRUS; FOOT-AND-MOUTH DISEASE VIRUS; GLUCOCORTICOIDS; GLYCYRRHIZIC ACID; HEPACIVIRUS; HUMANS; INTERFERONS; METHYLPREDNISOLONE; PROTEIN BIOSYNTHESIS; RIBAVIRIN; RIBONUCLEOPROTEINS; RIBOSOMES; RNA, DOUBLE-STRANDED; RNA, VIRAL; TUMOR CELLS, CULTURED; URSODEOXYCHOLIC ACID;

EID: 0037099367     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/341467     Document Type: Article

References (50)

1. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma
2. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis: A case-control study
3. Characteristic difference of hepatocellular carcinoma between hepatitis B and C viral infection in Japan
4. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
5. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis
6. Expression and identification of hepatitis C virus polyprotein cleavage products
7. Capping of eukaryotic mRNAs
8. Internal ribosomeentry site within hepatitis C virus RNA
9. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism
10. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA
11. The novel mechanism of initiation of picornavirus RNA translation
12. RNA-protein interactions in regulation of picornavirus RNA translation
13. Initiation of translation by picornavirus RNAs
14. Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes
15. Therapy of acute and chronic viral hepatitis
16. Glycyrrhizin as a potential treatment for chronic hepatitis C
17. Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis
18. A multicenter randomized controlled dose study of ursodeoxycholic acid for chronic hepatitis C
19. Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C
20. Hepatitis viruses under immunosuppressive agents
21. Translation efficiencies of the 5′ untranslated region from representatives of the six major genotypes of hepatitis C virus using a novel bicistronic reporter assay system
22. A single nucleotide substitution in the internal ribosome entry site of foot-and-mouth disease virus leads to enhanced cap-independent translation in vivo
23. Recognition of picornavirus internal ribosome entry sites within cells: Influence of cellular and viral proteins
24. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: Role of IRF1 and NF-κB
25. Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68,000-Mr protein kinase in a cell-free system
26. Lower concentration of La protein required for internal ribosome entry on hepatitis C virus RNA than on poliovirus RNA
27. Efficient selection for high-expression transfectants with a novel eukaryotic vector
28. A transforming growth factor b type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability
29. The first and third uORFs in RSV leader RNA are efficiently translated: Implications for translational regulation and viral RNA packaging
30. Detection and analysis of proteins expressed from cloned genes
31. Interactions between viruses and the cellular machinery for protein synthesis
32. PKR: A sentinel kinase for cellular stress
33. How cells respond to interferons
34. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein
35. Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins
36. MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line
37. Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus
38. A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication
39. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phos-phorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth
40. The La antigen binds 5′ noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation
41. Interaction of polypyrimidine tract-binding protein with the 5′ noncoding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of translation
42. Determination of the secondary structure of and cellular protein binding to the 3′-untranslated region of the hepatitis C virus RNA genome
43. Direct evidence that polypyrimidine tract binding protein (PTB) is essential for internal initiation of translation of encephalomyocarditis virus RNA
44. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways
45. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus
46. Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection
47. The interferon sensitivity determining region: All hepatitis C virus isolates are not the same
48. HCV viraemia is more important than genotype as a predictor of response to interferon in Sicily (southern Italy)
49. Mechanism of action of I-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broadspectrum antiviral agent
50. Action of the active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenase